FDA product code GXD: Generator, Lesion, Radiofrequency
GXD is the FDA product code for generator, lesion, radiofrequency. It is a Class II device, regulated under 21 CFR 882.4400 and reviewed by the Neurology panel. FDA has cleared 38 510(k) submissions under GXD, 7 in the last five years, from 28 different applicants. The average 510(k) review took 202 days (median 152); 175 days on average over the last three years. FDA has posted 7 recalls for GXD devices, 2 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Generator, Lesion, Radiofrequency |
| Device class | Class II |
| Regulation | 21 CFR 882.4400 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for GXD
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 120 |
| 2019 | 1 | 174 |
| 2020 | 2 | 146 |
| 2022 | 1 | 438 |
| 2023 | 2 | 301 |
| 2024 | 2 | 149 |
| 2025 | 1 | 106 |
| 2026 | 1 | 269 |
Compare with all 510(k) review times · Search every GXD clearance
Top GXD applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Radionics, Inc. | 4 | 1998-10-05 |
| Diros Technology, Inc. | 3 | 2010-01-22 |
| Avanos Medical, Inc. | 2 | 2024-08-14 |
| ABBOTT MEDICAL | 2 | 2022-01-21 |
| Neuro Therm, Inc. | 2 | 2011-09-20 |
23 more applicants have GXD clearances. See the full list in Caduvo.
Most recent GXD clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260337 | Dixi Medical | SEEG-Tx® System (STX-SYS-001) | 2026-10-29 | 269 |
| K251247 | Boston Scientific Neuromodulation Corporation | GX1 Radiofrequency Generator Kit (RFG-X1-120V); GX1 Radiofrequency Generator Kit (RFG-X1-220V); GX1 Radiofrequency Generator Kit (RFG-X1-240V); GX1 System Release Rest of World (GX1-SYS-ROW); GX1 Radiofrequency Generator (51779845-01); GX1 Radiofrequency Generator (51779845-02); GX1 Radiofrequency Generator (51779845-03) | 2025-08-07 | 106 |
| K242057 | Avanos Medical, Inc. | COOLIEF* Radiofrequency Generator (CRG-BASIC, CRG-BASIC-R, CRG-ADVANCED, CRG-ADVANCED-R) | 2024-08-14 | 30 |
| K232632 | Epimed International | Racz Neurostat RF Generator | 2024-05-24 | 268 |
| K231675 | Neuroone Medical Technologies Corp. | OneRF Ablation System | 2023-12-06 | 181 |
Recalls for GXD devices
7 product recalls in 7 recall events; 2 initiated in the last five years and 1 still open. Most recent: 2023-09-28.
| Year | Recalls |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Frequently asked questions
What is FDA product code GXD?
GXD is the FDA product code for generator, lesion, radiofrequency. It is a Class II device, regulated under 21 CFR 882.4400 and reviewed by the Neurology panel.
What device class is GXD?
Class II, regulation 21 CFR 882.4400. Typical premarket route: 510(k).
How long does a 510(k) take for product code GXD?
Across 38 cleared submissions the average was 202 days from receipt to decision (median 152).
Which companies have the most GXD clearances?
Radionics, Inc. (4); Diros Technology, Inc. (3); Avanos Medical, Inc. (2); ABBOTT MEDICAL (2); Neuro Therm, Inc. (2).
Have GXD devices been recalled?
Yes: 7 product recalls across 7 recall events; the most recent began 2023-09-28.
Next steps
- Run an FDA pathway report with predicate devices for product code GXD
- Run a recall and safety report across every GXD manufacturer
- Watch product code GXD for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times